The Future of MedTech Engagement: Connected, Mobile, and AI-Driven

Join Genpact for in this engaging session that will show you how to empower customer support agents with real-time and multilingual access to critical information, streamlined notetaking, and easier onboarding.

AdvaMed calls for federal privacy laws that reflect how medical devices use patient data differently from consumer health tools.

WASHINGTON—AdvaMed, the Medtech Association, welcomed introduction of the bipartisan Access to Prescription Digital Therapeutics Act of 2025 (S. 1702/H.R. 3288) by U.S. Sens. Shelley Moore Capito (R-W.Va.) and Jeanne Shaheen (D-N.H.) and U.S. Reps. Kevin Hern (R-Okla.) and Mike Thompson (D-Calif.). The bill provides for Medicare and Medicaid coverage of evidence-based software applications used to prevent, manage, or treat medical conditions.

Join Sunrise Labs in discussion of how in today’s climate of economic uncertainty, regulatory complexity, and constrained capital markets, securing investor funding is more challenging—and more vital—than ever for medtech companies. This executive-level webinar brings together seasoned leaders from across the medtech ecosystem to share proven strategies for building investor confidence and driving funding decisions. The session will offer actionable insights into how to communicate value, navigate risk, and chart a clear path from vision to viability.

Washington, D.C.—AdvaMed, the Medtech Association, today released its “AI Policy Roadmap,” a detailed policy outline for Congress and the federal agencies with jurisdiction over medtech to consider in promoting the next era of artificial intelligence-enabled medical and digital health technologies to provide patients and clinicians transformative new tools to aid in diagnosis and treatment. 

BOSTON and NEW YORK, April 14, 2025 /PRNewswire/ — Satio and Nanowear have agreed to partner to advance patient-friendly, home-based diagnostic, and therapeutic care. This collaboration integrates Nanowear’s at-home AI-based nanotechnology biomarker diagnostic platform with Satio’s at-home blood draw diagnostics and drug delivery systems/patches: combining time synchronous, in vivo and in vitro diagnostics for precision therapeutics and individualized AI-based risk assessment.

WASHINGTON – AdvaMed, the Medtech Association, today commended Senators Mike Rounds (R-SD) and Martin Heinrich (D-NM) for introducing the Health Tech Investment Act (S. 1399). This landmark bipartisan legislation will establish a stable reimbursement pathway for medical devices authorized by the U.S. Food & Drug Administration (FDA) that rely on artificial intelligence (AI) and machine learning (ML), also known as Algorithm-Based Healthcare Services (ABHS).

Each year, L.E.K. surveys approximately 200 senior hospital executives and administrators to uncover key strategic priorities, trends, challenges, and opportunities in the healthcare industry. Join the L.E.K. Medtech team as we share these valuable insights and discuss what this means for MedTech companies.